|
|
Blood, 15 May 2006, Vol. 107, No. 10, pp. 3925-3932.
Prepublished online as a Blood First Edition Paper on January 17, 2006; DOI 10.1182/blood-2005-11-4502.
Previous Article | Next Article 
Submitted November 14, 2005
Accepted December 30, 2005
Activated CD4+CD25+ T cells selectively kill B lymphocytes
Dong-Mei Zhao, Angela M Thornton, Richard J DiPaolo, and Ethan M Shevach*
Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
* Corresponding author; email: eshevach{at}niaid.nih.gov.
The suppressive capacity of naturally occurring mouse CD4+CD25+ T cells on T cell activation has been well documented. The present study is focused on the interaction of CD4+CD25+ T cells and B cells. By co-culturing pre-activated CD4+CD25+ T cells with B cells in the presence of polyclonal B cell activators, we found that B cell proliferation was significantly suppressed. The suppression of B cell proliferation was due to increased cell death caused by the CD4+CD25+ T cells in a cell-contact dependent manner. The induction of B cell death is not mediated by Fas-Fas ligand pathway, but surprisingly, depends on the up-regulation of perforin and granzymes in the CD4+CD25+ T cells. Furthermore, activated CD4+CD25+ T cells preferentially killed antigen presenting, but not bystander B cells. Our results demonstrate that CD4+CD25+ T cells can act directly on B cells and suggest that the prevention of autoimmunity by CD4+CD25+ T cells can be explained, at least in part, by the direct regulation of B cell function.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Tregs control B-cell life and death
- James J. Campbell
Blood 2006 107: 3818-3819.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
R. Houot, M. J. Goldstein, H. E. Kohrt, J. H. Myklebust, A. A. Alizadeh, J. T. Lin, J. M. Irish, J. A. Torchia, A. Kolstad, L. Chen, et al.
Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion
Blood,
October 15, 2009;
114(16):
3431 - 3438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sakaguchi, K. Wing, Y. Onishi, P. Prieto-Martin, and T. Yamaguchi
Regulatory T cells: how do they suppress immune responses?
Int. Immunol.,
October 1, 2009;
21(10):
1105 - 1111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Iikuni, E. V. Lourenco, B. H. Hahn, and A. La Cava
Cutting Edge: Regulatory T Cells Directly Suppress B Cells in Systemic Lupus Erythematosus
J. Immunol.,
August 1, 2009;
183(3):
1518 - 1522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Takahashi, Y. Kano, Y. Yamazaki, M. Kimishima, Y. Mizukawa, and T. Shiohara
Defective Regulatory T Cells In Patients with Severe Drug Eruptions: Timing of the Dysfunction Is Associated with the Pathological Phenotype and Outcome
J. Immunol.,
June 15, 2009;
182(12):
8071 - 8079.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Szymczak-Workman, C. J. Workman, and D. A. A. Vignali
Cutting Edge: Regulatory T Cells Do Not Require Stimulation through Their TCR to Suppress
J. Immunol.,
May 1, 2009;
182(9):
5188 - 5192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Andre, D. F. Tough, S. Lacroix-Desmazes, S. V. Kaveri, and J. Bayry
Surveillance of Antigen-Presenting Cells by CD4+CD25+ Regulatory T Cells in Autoimmunity: Immunopathogenesis and Therapeutic Implications
Am. J. Pathol.,
May 1, 2009;
174(5):
1575 - 1587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Bolitho, S. E. A. Street, J. A. Westwood, W. Edelmann, D. MacGregor, P. Waring, W. K. Murray, D. I. Godfrey, J. A. Trapani, R. W. Johnstone, et al.
Perforin-mediated suppression of B-cell lymphoma
PNAS,
February 24, 2009;
106(8):
2723 - 2728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Hou, H. S. Kang, and B. S. Kim
Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection
J. Exp. Med.,
February 16, 2009;
206(2):
313 - 328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Ludwig-Portugall, E. E. Hamilton-Williams, C. Gottschalk, and C. Kurts
Cutting Edge: CD25+ Regulatory T Cells Prevent Expansion and Induce Apoptosis of B Cells Specific for Tissue Autoantigens
J. Immunol.,
October 1, 2008;
181(7):
4447 - 4451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Gondek, V. DeVries, E. C. Nowak, L.-F. Lu, K. A. Bennett, Z. A. Scott, and R. J. Noelle
Transplantation Survival Is Maintained by Granzyme B+ Regulatory Cells and Adaptive Regulatory T Cells
J. Immunol.,
October 1, 2008;
181(7):
4752 - 4760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ota, M. Aoki-Ota, K. Tsunoda, T. Nishikawa, S. Koyasu, and M. Amagai
Autoreactive B-cell elimination by pathogenic IgG specific for the same antigen: implications for peripheral tolerance
Int. Immunol.,
October 1, 2008;
20(10):
1351 - 1360.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Zhao, C. Zhang, T. Yi, C.-L. Lin, I. Todorov, F. Kandeel, S. Forman, and D. Zeng
In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease
Blood,
September 1, 2008;
112(5):
2129 - 2138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lehe, H. Ghebeh, A. Al-Sulaiman, G. Al Qudaihi, K. Al-Hussein, F. Almohareb, N. Chaudhri, F. Alsharif, H. Al-Zahrani, A. Tbakhi, et al.
The Wilms' Tumor Antigen Is a Novel Target for Human CD4+ Regulatory T Cells: Implications for Immunotherapy
Cancer Res.,
August 1, 2008;
68(15):
6350 - 6359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Carvalho-Gaspar, N. D. Jones, S. Luo, L. Martin, M. O. Brook, and K. J. Wood
Location and Time-Dependent Control of Rejection by Regulatory T Cells Culminates in a Failure to Generate Memory T Cells
J. Immunol.,
May 15, 2008;
180(10):
6640 - 6648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Piconese, B. Valzasina, and M. P. Colombo
OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection
J. Exp. Med.,
April 14, 2008;
205(4):
825 - 839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Scabeni, M. Lapilla, S. Musio, B. Gallo, E. Ciusani, L. Steinman, R. Mantegazza, and R. Pedotti
CD4+CD25+ Regulatory T Cells Specific for a Thymus-Expressed Antigen Prevent the Development of Anaphylaxis to Self
J. Immunol.,
April 1, 2008;
180(7):
4433 - 4440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tzankov, C. Meier, P. Hirschmann, P. Went, S. A. Pileri, and S. Dirnhofer
Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
Haematologica,
February 1, 2008;
93(2):
193 - 200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. DiPaolo, C. Brinster, T. S. Davidson, J. Andersson, D. Glass, and E. M. Shevach
Autoantigen-Specific TGFbeta-Induced Foxp3+ Regulatory T Cells Prevent Autoimmunity by Inhibiting Dendritic Cells from Activating Autoreactive T Cells
J. Immunol.,
October 1, 2007;
179(7):
4685 - 4693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Moens, A. Jeurissen, R. S. Mittler, G. Wuyts, G. Michiels, L. Boon, J. L. Ceuppens, and X. Bossuyt
Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae
J. Leukoc. Biol.,
September 1, 2007;
82(3):
638 - 644.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Herve, I. Isnardi, Y.-s. Ng, J. B. Bussel, H. D. Ochs, C. Cunningham-Rundles, and E. Meffre
CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance
J. Exp. Med.,
July 9, 2007;
204(7):
1583 - 1593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Yakirevich and M. B. Resnick
Regulatory T Lymphocytes: Pivotal Components of the Host Antitumor Response
J. Clin. Oncol.,
June 20, 2007;
25(18):
2506 - 2508.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Guay, J. Larkin III, C. C. Picca, L. Panarey, and A. J. Caton
Spontaneous Autoreactive Memory B Cell Formation Driven by a High Frequency of Autoreactive CD4+ T Cells
J. Immunol.,
April 15, 2007;
178(8):
4793 - 4802.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Haribhai, W. Lin, L. M. Relland, N. Truong, C. B. Williams, and T. A. Chatila
Regulatory T Cells Dynamically Control the Primary Immune Response to Foreign Antigen
J. Immunol.,
March 1, 2007;
178(5):
2961 - 2972.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zeiser, V. H. Nguyen, J.-Z. Hou, A. Beilhack, E. Zambricki, M. Buess, C. H. Contag, and R. S. Negrin
Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease
Blood,
March 1, 2007;
109(5):
2225 - 2233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Callaghan, F. J. Rouhani, M. C. Negus, A. J. Curry, E. M. Bolton, J. A. Bradley, and G. J. Pettigrew
Abrogation of Antibody-Mediated Allograft Rejection by Regulatory CD4 T Cells with Indirect Allospecificity
J. Immunol.,
February 15, 2007;
178(4):
2221 - 2228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kotner and R. Tarleton
Endogenous CD4+ CD25+ Regulatory T Cells Have a Limited Role in the Control of Trypanosoma cruzi Infection in Mice
Infect. Immun.,
February 1, 2007;
75(2):
861 - 869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ralainirina, A. Poli, T. Michel, L. Poos, E. Andres, F. Hentges, and J. Zimmer
Control of NK cell functions by CD4+CD25+ regulatory T cells
J. Leukoc. Biol.,
January 1, 2007;
81(1):
144 - 153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Venet, A. Pachot, A.-L. Debard, J. Bohe, J. Bienvenu, A. Lepape, W. S. Powell, and G. Monneret
Human CD4+CD25+ Regulatory T Lymphocytes Inhibit Lipopolysaccharide-Induced Monocyte Survival through a Fas/Fas Ligand-Dependent Mechanism
J. Immunol.,
November 1, 2006;
177(9):
6540 - 6547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Carreras, A. Lopez-Guillermo, B. C. Fox, L. Colomo, A. Martinez, G. Roncador, E. Montserrat, E. Campo, and A. H. Banham
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma
Blood,
November 1, 2006;
108(9):
2957 - 2964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Wing, Z. Fehervari, and S. Sakaguchi
Emerging possibilities in the development and function of regulatory T cells
Int. Immunol.,
July 1, 2006;
18(7):
991 - 1000.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|